4.5 Review

The role of caspase-8 in the tumor microenvironment of ovarian cancer

Journal

CANCER AND METASTASIS REVIEWS
Volume 40, Issue 1, Pages 303-318

Publisher

SPRINGER
DOI: 10.1007/s10555-020-09935-1

Keywords

Tumor microenvironment; Caspase-8; Non-apoptotic functions; Macrophages; TAMs; Ovarian cancer treatment

Categories

Funding

  1. Projekt DEAL
  2. Deutsche Krebshilfe
  3. Deutsche Forschungsgemeinschaft
  4. Verein zur Forderung der Wissenschaft, Pravention and Therapie von Kehlkopfkrebs e.V.

Ask authors/readers for more resources

Caspase-8, a key regulator in multiple signaling pathways, not only controls cell cycle and behavior but also immune response and cytokine production within the tumor microenvironment. Dysregulated expression of caspase-8 in ovarian cancer influences tumor aggressiveness and immune resistance, highlighting its potential as a therapeutic target for developing new treatment strategies against the complex tumor microenvironment.
Caspase-8 is an aspartate-specific cysteine protease, which is best known for its apoptotic functions. Caspase-8 is placed at central nodes of multiple signal pathways, regulating not only the cell cycle but also the invasive and metastatic cell behavior, the immune cell homeostasis and cytokine production, which are the two major components of the tumor microenvironment (TME). Ovarian cancer often has dysregulated caspase-8 expression, leading to imbalance between its apoptotic and non-apoptotic functions within the tumor and the surrounding milieu. The downregulation of caspase-8 in ovarian cancer seems to be linked to high aggressiveness with chronic inflammation, immunoediting, and immune resistance. Caspase-8 plays therefore an essential role not only in the primary tumor cells but also in the TME by regulating the immune response, B and T lymphocyte activation, and macrophage differentiation and polarization. The switch between M1 and M2 macrophages is possibly associated with changes in the caspase-8 expression. In this review, we are discussing the non-apoptotic functions of caspase-8, highlighting this protein as a modulator of the immune response and the cytokine composition in the TME. Considering the low survival rate among ovarian cancer patients, it is urgently necessary to develop new therapeutic strategies to optimize the response to the standard treatment. The TME is highly heterogenous and provides a variety of opportunities for new drug targets. Given the variety of roles of caspase-8 in the TME, we should focus on this protein in the development of new therapeutic strategies against the TME of ovarian cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available